Table 2.
Demographic and Clinical Characteristics of the Samples (All Female Participants)
| Thinking and Living with Cancer Study (N=471) |
Mind Body Study (N=132) |
Cognition After Breast Cancer Study (N=90) |
|
|---|---|---|---|
| Age in years Mean (SD) Range |
69.6 (5.7) 60-92 |
56.4 (8.0) 36-69 |
48.7 (9.0) 24-65 |
| Years of Education | <16: 199 (42%) 1 16: 112 (24%) >16: 159 (34%) |
<16 26 (20%) 16 42 (32%) >16 63 (48%) |
<16 18 (20%) 16 34 (38%) >16 35 (39%) |
| Identified as Minority/non-white | 83 (18%) | 27 (21%) | 15 (17%) |
| Employed At Time of Study | 143 (30%)1 | 85 (64%) | 78 (87%) |
| Months Since Diagnosis Mean (SD) Range |
15.7 (2.67) 6.0-33.0 |
58.0 (8.1) 41.8-82.6 |
42.0 (32.4) 6.8 to 120 |
| Breast Cancer Stage 0 I II III |
79 (17%) 277 (60%) 88 (19%) 21 (5%) |
19 (15%) 58 (44%) 42 (32%) 12 (9%) |
19 (21%) 51 (57%) 19 (21%) |
| Frequency of Chemotherapy | 117 (25%) | 71 (54%) | 90 (100%) |
| Frequency of Radiation | 287 (61%) | 98 (75%) | 59 (66%) |
| Frequency of Hormone Therapy | 371 (80%) | 96 (73%) | 71 (79%) |
1
data available for n=470
Abbreviations: SD= standard deviation